StockData
Accendra Health Inc logo

Accendra Health Inc (ACCH) stock

ACCHWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31Also trades as ACH
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
Share price
Not available yet

Price, market cap and P/E appear here once daily prices are connected.

Accendra Health Inc saw revenue fall 7.1% to $2.55B over the twelve months to Sep 30, 2026. Free cash flow was -$199.12M. At the latest close the market valued the company at $10.00M.

Revenue
$2.55B
-7.1% vs. a year earlier
Operating income
$4.22M
TTM Q3 2026
Free cash flow
-$199.12M
TTM Q3 2026
EPS, diluted
-$2.23
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$10.00M
P/E ratio
–
Price to sales
0.00
Price to book
–
Dividend yield
–
Free cash flow yield
-1991.66%

Fundamentals

Revenue
$2.55B
Net income
-$171.56M
EPS, diluted
-$2.23
Free cash flow
-$199.12M
Book value per share
-$7.39
Diluted shares
77M

Trading

52-week range
$0.12 – $4.69
RSI (14 days)
22.7
Volatility (1 year)
112.7%
Relative volume
0.94×

Market cap history

Month-end market cap since 2010, using shares outstanding reported at the time

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$2.55B-7.1% YoY

Gross profit

$1.13B-35.8% YoY

Operating income

$4.22M

Net income

-$171.56M

EPS, diluted

-$2.23

Free cash flow

-$199.12M
Reported periodTrailing twelve months

Press releases

Releases Accendra Health filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Accendra Health

Wholesale-Medical, Dental & Hospital Equipment & Supplies

Accendra Health, Inc. provides medical supplies, technology, and home healthcare equipment across the United States. Its offerings focus on home respiratory therapy, obstructive sleep apnea treatment, diabetes care, wound care, and ostomy supplies. The company also delivers clinical support and patient management services designed to facilitate medical treatment outside acute care facilities. It operates primarily under brands such as Apria and Byram Healthcare, distributing products directly to individual patients as well as home health agencies. Reimbursement and payment arrangements involve commercial health insurers, managed care plans, state Medicaid programs, federal Medicare coverage, and direct out-of-pocket patient payments.

Company profile, executives and history

Accendra Health stock: common questions

What is ACCH's P/E ratio?

Accendra Health lost money over the twelve months to Sep 30, 2026 (diluted EPS -$2.23), so it has no meaningful P/E ratio.

How much revenue does Accendra Health make?

Accendra Health reported revenue of $2.55B for the twelve months to Sep 30, 2026, down 7.1% from a year earlier.

Does Accendra Health pay a dividend?

No. Accendra Health has not paid a cash dividend over the last twelve months.

How many ACCH shares are sold short?

10M shares were sold short at the latest FINRA report, 16.68% of the float, or 4.0 days of average trading volume.

Who are Accendra Health's competitors?

Companies most similar to Accendra Health by business, industry and size include HSIC, PLUS, AHCO, CNXN, SCSC.

See a number that looks wrong?